{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T14:01:31Z","timestamp":1783778491287,"version":"3.55.0"},"reference-count":32,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"unspecified","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00004\/03"],"award-info":[{"award-number":["MC_UU_00004\/03"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Second European & Developing Countries Clinical Trials Partnership","award":["RIA2016-1644"],"award-info":[{"award-number":["RIA2016-1644"]}]},{"name":"Gilead","award":["CO-UK-412-5430"],"award-info":[{"award-number":["CO-UK-412-5430"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["Strategic Core Award : 227167\/A\/23\/Z"],"award-info":[{"award-number":["Strategic Core Award : 227167\/A\/23\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,3,20]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Ensuring the effectiveness of HIV prevention and treatment methods requires high levels of adherence. Studies have recognised the significance of trust in shaping HIV risk perception.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>In this qualitative analysis, our aim was to explore risk perceptions and understand how individuals assess and respond to HIV risks, as well as their uptake and adherence to oral pre-exposure prophylaxis (PrEP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>The study was based on the setting of an HIV prevention trial conducted in South Africa.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Thirty individuals, 9% of the total clinical trial participants, enrolled in the clinical trial were purposively selected and interviewed at three time points within the trial during the follow-up phase. Data analysis was conducted using the Trust, Confidence and Cooperation framework that included constructs of trust, confidence and cooperation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The findings show that the ongoing participation in the clinical trial played a significant role in influencing participants\u2019 decision to continue PrEP as HIV prevention. This decision was grounded in their trust that PrEP would effectively reduce their vulnerability to HIV and infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Clear and consistent health-promoting initiatives enhance participants\u2019 self-awareness of HIV risks and promote understanding (uptake) and effectiveness of HIV prevention methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT04066881\">NCT04066881<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-086742","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T21:15:20Z","timestamp":1745442920000},"page":"e086742","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct04066881","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04066881","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04066881","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4890-2105","authenticated-orcid":false,"given":"Rujeko Samanthia","family":"Chimukuche","sequence":"first","affiliation":[{"name":"Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa"},{"name":"Division of Infection & Immunity, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Londiwe","family":"Shandu","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silindile","family":"Zulu","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phindile","family":"Khanyile","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishanta","family":"Singh","sequence":"additional","affiliation":[{"name":"HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakir","family":"Gaffoor","sequence":"additional","affiliation":[{"name":"HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5338-3517","authenticated-orcid":false,"given":"Rachel","family":"Kawuma","sequence":"additional","affiliation":[{"name":"Social Science, MRC\/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"McCormack","sequence":"additional","affiliation":[{"name":"MRC Clinical Trials Unit, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0583-5272","authenticated-orcid":false,"given":"Janet","family":"Seeley","sequence":"additional","affiliation":[{"name":"Africa Health Research Institute, Durban, KwaZulu-Natal, South Africa"},{"name":"Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"2025121604282280000_15.4.e086742.1","unstructured":"World Health Organisation . Policy brief: WHO expands recommendation on oral pre-exposure prophylaxis of HIV infection (PrEP). Geneva: World Health Organisation, 2015."},{"key":"2025121604282280000_15.4.e086742.2","unstructured":"World Health Organisation . Global health programme: pre-exposure prophylaxis (PrEP). Available: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/prevention\/pre-exposure-prophylaxis [Accessed 01 Mar 2024]."},{"key":"2025121604282280000_15.4.e086742.3","unstructured":"World Health Organisation . What\u2019s the 2+1+1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: update to WHO\u2019s recommendation on oral PrEP. 2019. Available: https:\/\/www.who.int\/publications\/i\/item\/what-s-the-2-1-1-event-driven-oral-pre-exposure-prophylaxis-to-prevent-hiv-for-men-who-have-sex-with-men [Accessed 10 Sep 2023]."},{"key":"2025121604282280000_15.4.e086742.4","unstructured":"PrEPWatch . Exploring data and information on PrEP across the globe. 2024. Available: https:\/\/www.prepwatch.org [Accessed 01 Mar 2024]."},{"key":"2025121604282280000_15.4.e086742.5","unstructured":"Joint United Nations Programme on HIV\/AIDS and the World Health Organization . Ethical considerations in HIV prevention trials. Geneva: WHO, 2021."},{"key":"2025121604282280000_15.4.e086742.6","doi-asserted-by":"crossref","first-page":"e495","DOI":"10.1016\/S2352-3018(21)00048-5","article-title":"Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study","volume":"8","author":"Donnell","year":"2021","journal-title":"Lancet HIV"},{"key":"2025121604282280000_15.4.e086742.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198680","article-title":"Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: A systematic literature review","volume":"13","author":"Warren","year":"2018","journal-title":"PLoS One"},{"key":"2025121604282280000_15.4.e086742.8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/1366987032000105315","article-title":"Perception of risk: the influence of general trust, and general confidence","volume":"8","author":"Siegrist","year":"2005","journal-title":"J Risk Res"},{"key":"2025121604282280000_15.4.e086742.9","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1007\/s10461-018-2044-2","article-title":"Motivated Reasoning and HIV Risk? Views on Relationships, Trust, and Risk from Young Women in Cape Town, South Africa, and Implications for Oral PrEP","volume":"22","author":"Hartmann","year":"2018","journal-title":"AIDS Behav"},{"key":"2025121604282280000_15.4.e086742.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-022-02018-z","article-title":"Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers","volume":"22","author":"Kayesu","year":"2022","journal-title":"BMC Womens Health"},{"key":"2025121604282280000_15.4.e086742.11","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s10461-023-04008-0","article-title":"HIV Risk Perception, Willingness to Use PrEP, and PrEP Uptake Among Young Men who have Sex with Men in Washington, DC","volume":"27","author":"Yellin","year":"2023","journal-title":"AIDS Behav"},{"key":"2025121604282280000_15.4.e086742.12","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13325"},{"key":"2025121604282280000_15.4.e086742.13","doi-asserted-by":"crossref","DOI":"10.3390\/healthcare9111597","article-title":"Media, Trust in Government, and Risk Perception of COVID-19 in the Early Stage of Epidemic: An Analysis Based on Moderating Effect","volume":"9","author":"Xu","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"2025121604282280000_15.4.e086742.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113517"},{"key":"2025121604282280000_15.4.e086742.15","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1504\/IJGENVI.2008.017257","article-title":"Trust, confidence and cooperation model: a framework for understanding the relation between trust and Risk Perception","volume":"8","author":"Earle","year":"2008","journal-title":"IJGENVI"},{"key":"2025121604282280000_15.4.e086742.16","doi-asserted-by":"crossref","unstructured":"Trust LM . Sociology of. In: Smelser NJ , Baltes PB , eds. International encyclopedia of the social & behavioral sciences. Oxford: Pergamon, 2001: 15922\u20136.","DOI":"10.1016\/B0-08-043076-7\/01983-5"},{"key":"2025121604282280000_15.4.e086742.17","unstructured":"UNAIDS . Joint UNAIDS-IAPAC fast-track cities project. 2022. Available: https:\/\/fasttrackcitiesmap.unaids.org\/cities\/durban-2\/ [Accessed 01 Mar 2024]."},{"key":"2025121604282280000_15.4.e086742.18","unstructured":"MRC\/UVRI and LSHTM Uganda Research Unit . A combination efficacy study in Africa of two DNA-MVA-Env protein or DNA-Env protein HIV-1 vaccine regimens with PrEP (PrEPVacc). US National Library of Medicine, 2019. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04066881"},{"key":"2025121604282280000_15.4.e086742.19","unstructured":"MRC\/UVRI and LSHTM Uganda Research Unit . PrEPVacc: a phase IIb three-arm, two-stage HIV prophylactic vaccine trial with a second randomisation to compare TAF\/FTC to TDF\/FTC as pre-exposure prophylaxis. Version 5.0. 2021. Available: https:\/\/www.prepvacc.org\/vacc [Accessed 01 Mar 2024]."},{"key":"2025121604282280000_15.4.e086742.20","doi-asserted-by":"publisher","DOI":"10.1007\/s10508-012-0016-6"},{"key":"2025121604282280000_15.4.e086742.21","doi-asserted-by":"crossref","DOI":"10.1186\/s12981-019-0229-z","article-title":"HIV risk, risk perception and uptake of HIV testing and counseling among youth men who have sex with men attending a gay sauna","volume":"16","author":"Khawcharoenporn","year":"2019","journal-title":"AIDS Res Ther"},{"key":"2025121604282280000_15.4.e086742.22","doi-asserted-by":"publisher","DOI":"10.1023\/B:AIBE.0000030244.92791.63"},{"key":"2025121604282280000_15.4.e086742.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-021-06689-1","article-title":"Effect of perceived HIV risk on initiation of antiretroviral therapy during the universal test and treat era in South Africa","volume":"21","author":"Govere","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2025121604282280000_15.4.e086742.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12905-023-02603-w","article-title":"Changes in relationships, HIV risk, and feelings towards PrEP: findings from a qualitative explanatory study among participants in the CHARISMA intervention trial","volume":"23","author":"Hartmann","year":"2023","journal-title":"BMC Womens Health"},{"key":"2025121604282280000_15.4.e086742.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0277-9536(98)00194-4"},{"key":"2025121604282280000_15.4.e086742.26","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1080\/17441692.2015.1019538","article-title":"Trust matters: A narrative literature review of the role of trust in health care systems in sub-Saharan Africa","volume":"10","author":"\u00d8stergaard","year":"2015","journal-title":"Glob Public Health"},{"key":"2025121604282280000_15.4.e086742.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2004.11.059"},{"key":"2025121604282280000_15.4.e086742.28","doi-asserted-by":"publisher","DOI":"10.1108\/14777260610701768"},{"key":"2025121604282280000_15.4.e086742.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258542","article-title":"Adolescent girls and young women\u2019s PrEP-user journey during an implementation science study in South Africa and Kenya","volume":"16","author":"Rousseau","year":"2021","journal-title":"PLoS One"},{"key":"2025121604282280000_15.4.e086742.30","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-023-16139-z","article-title":"Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa","volume":"23","author":"Beesham","year":"2023","journal-title":"BMC Public Health"},{"key":"2025121604282280000_15.4.e086742.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-06920-4","article-title":"A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa","volume":"21","author":"Rousseau","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2025121604282280000_15.4.e086742.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-19152-y","article-title":"Barriers and facilitators to uptake and persistence on prep among key populations in Southern Province, Zambia: a thematic analysis","volume":"24","author":"Stoebenau","year":"2024","journal-title":"BMC Public Health"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-086742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:28:34Z","timestamp":1765888114000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-086742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,23]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bmjopen-2024-086742"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-086742","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}